Literature DB >> 3478739

Increased aortic thromboxane production in experimental atherosclerosis.

P Henriksson1, M Stamberger, U Diczfalusy.   

Abstract

It is of great importance to clarify the role of thromboxane and prostacyclin in the process of atherosclerosis. In order to study this we induced atherosclerosis in rabbits through cholesterol feeding (1% w/w) for three to 12 weeks. After sacrifice the aorta was quickly removed and incubated. The in vitro thromboxane production measured as immunoreactive thromboxane B2 increased by 86 per cent in atherosclerotic vessels compared to control vessels (p less than 0.0005). The in vitro production of prostacyclin measured as immunoreactive 6-keto-prostaglandin F1 alpha showed a tendency to higher values in the atherosclerotic vessels compared to the control vessels (31%, p less than 0.025). This suggests that an increased thromboxane production rather than a decreased prostacyclin production might be important for the progression of atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3478739     DOI: 10.1016/0262-1746(87)90098-9

Source DB:  PubMed          Journal:  Prostaglandins Leukot Med        ISSN: 0262-1746


  3 in total

1.  The antioxidant butylated hydroxytoluene prevents early cholesterol-induced microcirculatory changes in rabbits.

Authors:  R J Xiu; A Freyschuss; X Ying; L Berglund; P Henriksson; I Björkhem
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

2.  Mevalonate availability affects human and rat resistance vessel function.

Authors:  J B Roullet; H Xue; C M Roullet; W S Fletcher; M J Cipolla; C T Harker; D A McCarron
Journal:  J Clin Invest       Date:  1995-07       Impact factor: 14.808

3.  Hypercholesterolemia increases plasma saturated and n-6 fatty acids altering prostaglandin homeostasis and promotes endothelial dysfunction in rabbits.

Authors:  M Medina; M R Alberto; L Sierra; C Van Nieuwenhove; S Saad; M I Isla; S Jerez
Journal:  Lipids       Date:  2014-06-01       Impact factor: 1.880

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.